Cargando…
Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL
Acute myeloid leukemia (AML) patients with minimal residual disease and receiving allogeneic hematopoietic stem cell transplantation (HCT) have poor survival. Adoptive administration of dendritic cells (DCs) presenting the Wilms tumor protein 1 (WT1) leukemia-associated antigen can potentially stimu...
Autores principales: | Bialek-Waldmann, Julia K., Domning, Sabine, Esser, Ruth, Glienke, Wolfgang, Mertens, Mira, Aleksandrova, Krasimira, Arseniev, Lubomir, Kumar, Suresh, Schneider, Andreas, Koenig, Johannes, Theobald, Sebastian J., Tsay, Hsin-Chieh, Cornelius, Angela D.A., Bonifacius, Agnes, Eiz-Vesper, Britta, Figueiredo, Constanca, Schaudien, Dirk, Talbot, Steven R., Bleich, Andre, Spineli, Loukia M., von Kaisenberg, Constantin, Clark, Caren, Blasczyk, Rainer, Heuser, Michael, Ganser, Arnold, Köhl, Ulrike, Farzaneh, Farzin, Stripecke, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142053/ https://www.ncbi.nlm.nih.gov/pubmed/34095345 http://dx.doi.org/10.1016/j.omtm.2021.04.004 |
Ejemplares similares
-
Accumulation of T-cell-suppressive PD-L1(high) extracellular vesicles is associated with GvHD and might impact GvL efficacy
por: Baur, Rebecca, et al.
Publicado: (2023) -
Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers
por: Li, Yan-Ruide, et al.
Publicado: (2022) -
Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells
por: Tischer, Sabine, et al.
Publicado: (2014) -
Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms
por: Priesner, Christoph, et al.
Publicado: (2016) -
Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy
por: Laubert, Miriam, et al.
Publicado: (2022)